Omega-3 fatty acids in depression: What’s going on? 1 CME Point
EVENT TYPE: ONLINE
Speakers
Dr Simon Dyall
SPEAKER
Dr Simon Dyall leads the MSc Clinical Neuroscience programme at the University of Roehampton, and is Honorary Visiting Research Fellow in the Centre for Neuroscience, Surgery and Trauma, Queen Mary University of London. He is Chair of the Scientific Advisory Board of the U.K. Association of Milk Banking and in addition to twice being elected to the Board of Directors of the International Society for the Study of Fatty Acids and Lipids (ISSFAL), is on the Scientific Advisory Boards of the charities, Think Through Nutrition, and Food For the Brain Foundation, and is on the Editorial Board of the journal, Lipids in Health and Disease. His research sits at the interface of neuroscience, nutrition, neurobiology and psychology (Nutritional Neuroscience). His Neuroactive Lipids Lab utilises both pre-clinical and clinical approaches to explore the role of bioactive lipids in brain health and disease across the lifespan. Current projects include exploring the role of polyunsaturated fatty acids and lipid mediators in perinatal health, and a neuroimaging study investigating the therapeutic effects of a high omega-3 fatty acid multinutrient supplement on stress and anxiety in young adults.
AGENDA
- The role of omega-3 fatty acids in depression.
- The pathophysiological mechanisms related to depression.
- The correlation of dietary patterns with mental health disorders, specifically depression.
- The current evidence supporting the role of omega-3 fatty acids in prevention of depression, and best evidence based practice.